Population
A 65-year-old woman with COVID-19 and fulminant myocarditis
Design
Case report and review of literature
Follow-up
One month
Authors
Loading...
May support ECMO and immunomodulation for survival in select COVID-19 fulminant myocarditis cases; leaves open need for controlled trials.
COVID-19 can cause fulminant myocarditis presenting with atypical symptoms, which may require aggressive interventions like ECMO, high-dose steroids, and IVIG for survival.
Wang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: